<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To evaluate the relative impact of abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo> and newly diagnosed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> on insulin action in skeletal muscle and fat tissue, we studied 61 men with (n = 31) or without (n = 30) <z:mp ids='MP_0002055'>diabetes</z:mp>, subgrouped into abdominally <z:mp ids='MP_0001261'>obese</z:mp> or nonobese according to the waist circumference </plain></SENT>
<SENT sid="1" pm="."><plain>Adipose tissue depots were quantified by magnetic resonance imaging, and regional <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake was measured using 2-[(18)F]fluoro-2-<z:chebi fb="0" ids="15866">deoxyglucose</z:chebi>/<z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography during euglycemic <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Across groups, <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake per unit tissue weight was higher in visceral (20.5 +/- 1.4 micromol  </plain></SENT>
<SENT sid="3" pm="."><plain>min(-1)  </plain></SENT>
<SENT sid="4" pm="."><plain>kg(-1)) than in abdominal (9.8 +/- 0.9 micromol min(-1)  </plain></SENT>
<SENT sid="5" pm="."><plain>kg(-1), P &lt; 0.001) or femoral (12.3 +/- 0.6 micromol  </plain></SENT>
<SENT sid="6" pm="."><plain>min(-1)  </plain></SENT>
<SENT sid="7" pm="."><plain>kg(-1), P &lt; 0.001) subcutaneous tissue and approximately 40% lower than in skeletal muscle (33.1 +/- 2.5 micromol  </plain></SENT>
<SENT sid="8" pm="."><plain>min(-1)  </plain></SENT>
<SENT sid="9" pm="."><plain>kg(-1), P &lt; 0.0001) </plain></SENT>
<SENT sid="10" pm="."><plain>Abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo> was associated with a marked reduction in <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake per unit tissue weight in <z:hpo ids='HP_0000001'>all</z:hpo> fat depots and in skeletal muscle (P &lt; 0.001 for <z:hpo ids='HP_0000001'>all</z:hpo> regions) </plain></SENT>
<SENT sid="11" pm="."><plain>Recent type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> per se had little additional effect </plain></SENT>
<SENT sid="12" pm="."><plain>In both intra-abdominal adipose (r = -0.73, P &lt; 0.0001) and skeletal muscle (r = -0.53, P &lt; 0.0001) tissue, <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake was reciprocally related to intra-abdominal fat mass in a curvilinear fashion </plain></SENT>
<SENT sid="13" pm="."><plain>When regional <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake was multiplied by tissue mass, total <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake per fat depot was similar irrespective of abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo> or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and its contribution to whole-body <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake increased by approximately 40% in <z:mp ids='MP_0001261'>obese</z:mp> nondiabetic and nonobese diabetic men and was doubled in <z:mp ids='MP_0001261'>obese</z:mp> diabetic subjects </plain></SENT>
<SENT sid="14" pm="."><plain>We conclude that 1) in abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo>, insulin-stimulated <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake rate is markedly reduced in skeletal muscle and in <z:hpo ids='HP_0000001'>all</z:hpo> fat depots; 2) in target tissues, this reduction is reciprocally (and nonlinearly) related to the amount of intra-abdominal fat; 3) mild, recent <z:mp ids='MP_0002055'>diabetes</z:mp> adds little <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> to that caused by abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo>; and 4) despite fat <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, an expanded fat mass (especially subcutaneous) provides a sink for <z:chebi fb="105" ids="17234">glucose</z:chebi>, resulting in a compensatory attenuation of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> at the whole-body level in men </plain></SENT>
</text></document>